St. Johns Investment Management’s GSK GSK Stock Holding History

St. Johns Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-80	Closed	-$3.27K	–	221
2024 Q3	$3.27K	Buy	+80	New	+$3.27K	﹤0.01%	167
2021 Q4	–	Sell	-508	Closed	-$24K	–	192
2021 Q3	$24K	Hold	508	–	–	0.01%	108
2021 Q2	$25K	Hold	508	–	–	0.01%	108
2021 Q1	$23K	Hold	508	–	–	0.01%	108
2020 Q4	$23K	Hold	508	–	–	0.01%	103
2020 Q3	$24K	Sell	508 -404	-44%	-$20.2K	0.02%	100
2020 Q2	$47K	Hold	912	–	–	0.03%	98
2020 Q1	$43K	Hold	912	–	–	0.04%	88
2019 Q4	$54K	Sell	912 -570	-38%	-$31.7K	0.04%	90
2019 Q3	$79K	Hold	1,482	–	–	0.06%	83
2019 Q2	$74K	Sell	1,482 -593	-29%	-$29.8K	0.06%	86
2019 Q1	$108K	Hold	2,075	–	–	0.08%	86
2018 Q4	$99K	Sell	2,075 -400	-16%	-$19.7K	0.09%	82
2018 Q3	$124K	Sell	2,475 -176	-7%	-$8.94K	0.09%	82
2018 Q2	$134K	Hold	2,651	–	–	0.1%	85
2018 Q1	$129K	Hold	2,651	–	–	0.1%	82
2017 Q4	$118K	Sell	2,651 -228	-8%	-$10.5K	0.09%	85
2017 Q3	$146K	Hold	2,879	–	–	0.11%	85
2017 Q2	$155K	Hold	2,879	–	–	0.12%	84
2017 Q1	$152K	Hold	2,879	–	–	0.12%	80
2016 Q4	$139K	Hold	2,879	–	–	0.11%	79
2016 Q3	$155K	Hold	2,879	–	–	0.13%	81
2016 Q2	$156K	Hold	2,879	–	–	0.14%	78
2016 Q1	$146K	Hold	2,879	–	–	0.13%	79
2015 Q4	$145K	Hold	2,879	–	–	0.13%	79
2015 Q3	$138K	Buy	+2,879	New	+$150K	0.13%	78

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

St. Johns Investment Management's GSK Position: Q4 2024 in Review

St. Johns Investment Management sold out of GSK (GSK) in Q4 2024, closing a stake of 80 shares — an estimated $3.27K sold.

St. Johns Investment Management first reported a position in GSK in Q3 2015 and held it in 26 quarters. The position peaked at $156K in Q2 2016. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

St. Johns Investment Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
St. Johns Investment Management sold 80 GSK shares in Q4 2024, an estimated $3.27K.
St. Johns Investment Management first reported a position in GSK in Q3 2015 and held it in 26 quarters.
St. Johns Investment Management's GSK position peaked at $156K in Q2 2016.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on St. Johns Investment Management's 13F filing for Q4 2024, filed 21 Jan 2025.